These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21600023)

  • 1. Optimizing cost-efficiency in mean exposure assessment--cost functions reconsidered.
    Mathiassen SE; Bolin K
    BMC Med Res Methodol; 2011 May; 11():76. PubMed ID: 21600023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost and statistical efficiency of posture assessment by inclinometry and observation, exemplified by paper mill work.
    Mathiassen SE; Waleh Åström A; Strömberg A; Heiden M
    PLoS One; 2023; 18(10):e0292261. PubMed ID: 37788296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy and precision of variance components in occupational posture recordings: a simulation study of different data collection strategies.
    Liv P; Mathiassen SE; Svendsen SW
    BMC Med Res Methodol; 2012 Jun; 12():58. PubMed ID: 22533627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Too many cohorts and repeated measurements are a waste of resources.
    Tekle FB; Tan FE; Berger MP
    J Clin Epidemiol; 2011 Dec; 64(12):1383-90. PubMed ID: 21592727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal sample size allocation for Welch's test in one-way heteroscedastic ANOVA.
    Shieh G; Jan SL
    Behav Res Methods; 2015 Jun; 47(2):374-83. PubMed ID: 24903689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical and empirical efficiency of sampling strategies for estimating upper arm elevation.
    Liv P; Mathiassen SE; Svendsen SW
    Ann Occup Hyg; 2011 May; 55(4):436-49. PubMed ID: 21486917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-efficient design of occupational exposure assessment strategies--a review.
    Rezagholi M; Mathiassen SE
    Ann Occup Hyg; 2010 Nov; 54(8):858-68. PubMed ID: 20926518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
    Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
    Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing power in allocating resources to exposure assessment in an epidemiologic study.
    Armstrong BG
    Am J Epidemiol; 1996 Jul; 144(2):192-7. PubMed ID: 8678052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.
    Hernández Alava M; Wailoo A; Pudney S; Gray L; Manca A
    Health Technol Assess; 2020 Jun; 24(34):1-68. PubMed ID: 32613941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size calculation in cost-effectiveness cluster randomized trials: optimal and maximin approaches.
    Manju MA; Candel MJ; Berger MP
    Stat Med; 2014 Jul; 33(15):2538-53. PubMed ID: 25019136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal sample sizes for Welch's test under various allocation and cost considerations.
    Jan SL; Shieh G
    Behav Res Methods; 2011 Dec; 43(4):1014-22. PubMed ID: 21512873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Benefit Analysis for Optimization of Risk Protection Under Budget Constraints.
    Špačková O; Straub D
    Risk Anal; 2015 May; 35(5):941-59. PubMed ID: 25676128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing dengue fever cases at the lowest budget: a constrained optimization approach applied to Thailand.
    Knerer G; Currie CSM; Brailsford SC
    BMC Public Health; 2021 Apr; 21(1):807. PubMed ID: 33906628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal contrast analysis with heterogeneous variances and budget concerns.
    Jan SL; Shieh G
    PLoS One; 2019; 14(3):e0214391. PubMed ID: 30913244
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.